We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
To help you protect, manage and enforce your intellectual property (IP) rights in Vietnam.
Statistics showing the number of signals passed at danger (SPADs) without authority.
Critical services will be better safeguarded, thanks to £155 million government investment to boost national security and deliver national renewal.
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Statistics showing the number of signals passed at danger (SPADs) without authority in each quarter since 1998 to 1999 (quarter 4) in Great Britain.
Benefit-Risk Submission Report (BRSR) and Pharmacovigilance Sales Submission (PSS) templates and guidance for completion of BRSRs, PSSs and signal notifications.
How to write clear and effective field safety notices (FSNs) for medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).